Platforms and infrastructure
We are building a robotically integrated, AI-assisted pandemic response engine enabling swift, decisive action against emerging bacterial threats in Canada.
Infrastructure to accelerate preclinical drug discovery in AMR
Our consortium has identified key research infrastructure needs to help Canada better prepare for AMR pandemics. We are currently building scientific platforms to address these needs, to develop an integrated, AI-propelled rapid antimicrobial discovery engine for AMR pandemics.
All infrastructure is being integrated into existing core facilities at our partner institutions. We build upon prior Canadian investments and leverage existing highly-specialized technical, managerial and operational resources, to serve current and future research initiatives.
A pan-Canadian pipeline for AMR drug discovery
